Blog Archive
-
▼
2008
(233)
-
▼
May
(27)
- Pipex Pharmaceuticals : Oral Flupirtine Patent Est...
- Daiichi Sankyo : AZOR Reduces Blood Pressure in Di...
- DiaMedica : pre-IND FDA Guidance on DM-71
- ALR Technologies : ECHO of Alabama Employer Coalit...
- AtheroGenics : ARISE Trial Results Published in Th...
- Daiichi Sankyo : Welchol, Combined With Metformin ...
- DiaMedica : Enrollment in Phase II Clinical Trial ...
- Allon : potential of AL-309 as a new neuropathy tr...
- Entelos : Agreement with Lilly
- FivePrime and Pfizer : Diabetes Collaboration
- Diasome Pharmaceuticals : at the 68th Annual Ameri...
- Phenomix : PHX1149 Phase 2b Clinical Trial Results...
- Aradigm : Data Showing No Occurrence of Primary Lu...
- MicroIslet : Collaboration With DiaKine Intended T...
- CytRx : Discovery of Novel Compounds that Amplify ...
- RegeneRx : Ophthalmic Patent in Hong Kong
- Elixir Pharmaceuticals : Issuance of SIRT Patent C...
- OXiGENE : Active Metabolite of ZYBRESTAT Improves...
- Incyte : Positive Clinical Progress
- Merck's JANUMET (sitagliptin/metformin HCl) Recomm...
- Pfizer : Research Consortium to Expand Understandi...
- NOVAGALI : First Patient in U.S. Phase I Clinical ...
- Solianis Monitoring : Non-Invasive Glucose Monitoring
- Nektar Terminates All Negotiations With Potential ...
- CureDM : Diabetes Therapy Major Development Achieved
- Biocon Limited : Phase IIa Clinical Trials for IN105
- Toumaz Technology and Consortium Partners : Major ...
-
▼
May
(27)
Monday, May 5, 2008
CureDM : Diabetes Therapy Major Development Achieved
April 30, 2008 - CureDM, Inc., a biopharmaceutical company developing new therapies that prevent, ameliorate, or reverse both type 1 and 2 diabetes, announces its achievement of a major drug development milestone for Human proIslet Peptide (HIP). CureDM has successfully stabilized HIP to improve its bioavailability with recent dose response studies indicating that the dosage used in man may be as much as 100-fold lower than the native form. HIP is a 14-amino acid human peptide derived from a specific human gene responsible for populating the pancreas with islets, which contain the cells that secrete insulin and other hormones necessary to prevent diabetes... [PDF] CureDM's Press Release -
Libellés :
CureDM,
Type 1 Diabetes,
Type 2 Diabetes